Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients

NCT07125729 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Resectable Colorectal Carcinoma
Stage II Colorectal Cancer AJCC v8
Stage III Colorectal Cancer AJCC v8
Stage IV Colorectal Cancer AJCC v8

Interventions

PROCEDURE: Biospecimen Collection
OTHER: cfDNA or ctDNA Measurement
OTHER: Electronic Health Record Review

Sponsor

City of Hope Medical Center

Collaborators

[object Object]